ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00481559
Recruitment Status : Approved for marketing
First Posted : June 1, 2007
Last Update Posted : January 17, 2014
Sponsor:
Collaborator:
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
BTG International Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Approved for marketing
  Primary Completion Date : No date given
  Study Completion Date : No date given